Pacira Pharmaceuticals, Inc.

Jonathan H Slonin

Roy Winston

Stan Dysart

Jared Ham

Embodiments of the present disclosure relate to the use of bupivacaine multivesicular liposomes (MVLs) as stellate ganglion block (SGB) for treating or ameliorating various diseases and conditions, including but not limited to cardiac electrical storm or cardiac arrythmia/dysrhythmia following heart surgery.

Uses of bupivacaine multivesicular liposomes as stellate ganglion block

In some embodiments provided herein is a method of treating hip pain in a subject, the method comprising administering into the subject a pharmaceutical composition comprising: a) a multivesicular liposome comprising: at least one amphipathic lipid, and at least one neutral lipid; and b) an aqueous phase comprising bupivacaine phosphate, wherein the aqueous phase is encapsulated within the multivesicular liposome.

Growing community of inventors

Palm City, FL, United States of America

Jonathan H Slonin